Detalhe da pesquisa
1.
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis.
Cancer Cell
; 41(4): 740-756.e10, 2023 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36963401
2.
Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers.
Cancer Res
; 81(20): 5325-5335, 2021 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34548333
3.
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer.
Nat Commun
; 12(1): 5321, 2021 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34493732
4.
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.
Nat Cancer
; 2(2): 189-200, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34085048
5.
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.
Cancer Res
; 80(4): 890-900, 2020 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31857293
6.
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.
Cancer Res
; 79(21): 5482-5489, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31311810
7.
ARID1A promotes genomic stability through protecting telomere cohesion.
Nat Commun
; 10(1): 4067, 2019 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31492885
8.
NAD+ metabolism governs the proinflammatory senescence-associated secretome.
Nat Cell Biol
; 21(3): 397-407, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30778219
9.
Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.
Cancer Res
; 76(8): 2137-52, 2016 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26951929